DOI QR코드

DOI QR Code

Cytoprotection Against Oxidative Damage by Nrf2-regulated Genes

  • Kwak, Mi-Kyoung (College of Pharmacy, Yeungnam University) ;
  • Kensler, Thomas W. (Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health)
  • Published : 2007.09.30

Abstract

Chronic oxidative stress produced by exposure to environmental chemicals or pathophysiological states can lead animals to aging, carcinogenesis and degenerative diseases. Indirect antioxidative mechanisms, in which natural or synthetic agents are used to coordinately induce the expression of cellular antioxidant capacity, have been shown to protect cells and organisms from oxidative damages. Electrophile and free radical detoxifying enzymes, which were originally identified as the products of genes induced by cancer chemopreventive agents, are members of this protective system. The NFE2 family transcription factor Nrf2 was found to govern expression of these detoxifying enzymes, and screening for Nrf2-regulated genes has identified many gene categories involved in maintaining cellular redox potential and protection from oxidative damage as Nrf2 downstream genes. Further, studies using Nrf2-deficient mice revealed that these mutant mice showed more susceptible phenotypes towards exposure to environmental chemicals/carcinogens and in oxidative stress related disease models. With the finding that cancer chemopreventive efficacy of indirect antioxidants (enzyme inducers) is lost in the absence of Nrf2, a central role of Nrf2 in the antioxidative protective system has been firmly established. Promising results from cancer prevention clinical trials using enzyme inducers propose that pharmacological interventions that modulate Nrf2 can be an effective strategy to protect tissues from oxidative damage.

Keywords

References

  1. Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K. and Yamamoto, M. (2001). Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol., 173, 154-160 https://doi.org/10.1006/taap.2001.9176
  2. Chan, K., Han, X.D. and Kan, Y.W. (2001). An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA, 98, 4611-4616
  3. Chan, K. and Kan, Y.W. (1999). Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. USA, 96, 12731-12736
  4. Chen, C. and Kong, A.N. (2004). Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic. Biol. Med., 36, 1505-1516 https://doi.org/10.1016/j.freeradbiomed.2004.03.015
  5. Cho, H.Y., Jedlicka, A.E., Reddy, S.P., Kensler, T.W., Yamamoto, M., Zhang, L.Y. and Kleeberger, S.R. (2002a). Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol., 26, 175-182 https://doi.org/10.1165/ajrcmb.26.2.4501
  6. Cho, H.Y., Jedlicka, A.E., Reddy, S.P., Zhang, L.Y., Kensler, T.W. and Kleeberger, S.R. (2002b). Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am. J. Respir. Cell Mol. Biol., 26, 42-51 https://doi.org/10.1165/ajrcmb.26.1.4536
  7. Cho, H.Y., Reddy, S.P., Yamamoto, M. and Kleeberger, S.R.(2004). The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J., 18, 1258-1260 https://doi.org/10.1096/fj.03-1127fje
  8. Cho, M.K., Kim, W.D., Ki, S.H., Hwang, J.I., Choi, S., Lee, C.H. and Kim, S.G. (2007). Role of G{alpha}12 and G{alpha}13 as novel switches for the activity of Nrf2, a key antioxidative transcription factor. Mol. Cell Biol., 27, 6195-6208 https://doi.org/10.1128/MCB.02065-06
  9. Dick, R.A., Kwak, M.K., Sutter, T.R. and Kensler, T.W. (2001). Antioxidative function and substrate specificity of NAD(P)Hdependent alkenal/one oxidoreductase. A new role for leukotriene B4 12- hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J. Biol. Chem., 276, 40803-40810 https://doi.org/10.1074/jbc.M105487200
  10. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T. and Yamamoto, M. (2001). High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of AREregulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci., 59, 169-177 https://doi.org/10.1093/toxsci/59.1.169
  11. Huang, H.C., Nguyen, T. and Pickett, C.B. (2002). Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem., 277, 42769-42774 https://doi.org/10.1074/jbc.M206911200
  12. Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S. and Yamamoto, M. (2000). Transcription factor Nrf2 coordinately regulates a group of oxidative stressinducible genes in macrophages. J. Biol. Chem., 275, 16023-16029 https://doi.org/10.1074/jbc.275.21.16023
  13. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. and Nabeshima, Y. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun., 236, 313-322 https://doi.org/10.1006/bbrc.1997.6943
  14. Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K. and Yamamoto, M. (2004). Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol. Cell Biol., 24, 36-45 https://doi.org/10.1128/MCB.24.1.36-45.2004
  15. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D. and Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev., 13, 76-86 https://doi.org/10.1101/gad.13.1.76
  16. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T. and Yamamoto, M. (2003). Keap1 regulates both cytoplasmic- nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells, 8, 379-391 https://doi.org/10.1046/j.1365-2443.2003.00640.x
  17. Kang, K.W., Cho, M.K., Lee, C.H. and Kim, S.G. (2001). Activation of phosphatidylinositol 3-kinase and Akt by tertbutylhydroquinone is responsible for antioxidant response element-mediated rGSTA2 induction in H4IIE cells. Mol. Pharmacol., 59, 1147-1156 https://doi.org/10.1124/mol.59.5.1147
  18. Kang, K.W., Ryu, J.H. and Kim, S.G. (2000). The essential role of phosphatidylinositol 3-kinase and of p38 mitogenactivated protein kinase activation in the antioxidant response element-mediated rGSTA2 induction by decreased glutathione in H4IIE hepatoma cells. Mol. Pharmacol., 58, 1017-1025 https://doi.org/10.1124/mol.58.5.1017
  19. Kensler, T.W. (1997). Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect, 105, 965-970 https://doi.org/10.2307/3433311
  20. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K. and Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell Biol., 24, 7130-7139 https://doi.org/10.1128/MCB.24.16.7130-7139.2004
  21. Kwak, M.K., Cho, J.M., Huang, B., Shin, S. and Kensler, T.W. (2007). Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic. Biol. Med., 43, 809-817 https://doi.org/10.1016/j.freeradbiomed.2007.05.029
  22. Kwak, M.K., Egner, P.A., Dolan, P.M., Ramos-Gomez, M., Groopman, J.D., Itoh, K., Yamamoto, M. and Kensler, T.W. (2001a). Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res., 480-481, 305-315
  23. Kwak, M.K., Itoh, K., Yamamoto, M. and Kensler, T.W. (2002). Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol. Cell Biol., 22, 2883-2892 https://doi.org/10.1128/MCB.22.9.2883-2892.2002
  24. Kwak, M.K., Itoh, K., Yamamoto, M., Sutter, T.R. and Kensler, T.W. (2001b). Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole- 3-thione. Mol. Med., 7, 135-145
  25. Kwak, M.K., Ramos-Gomez, M., Wakabayashi, N. and Kensler, T.W. (2004). Chemoprevention by 1,2-dithiole-3-thiones through induction of NQO1 and other phase 2 enzymes. Methods Enzymol., 382, 414-423 https://doi.org/10.1016/S0076-6879(04)82022-6
  26. Kwak, M.K., Wakabayashi, N., Greenlaw, J.L., Yamamoto, M. and Kensler, T.W. (2003a). Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell Biol., 23, 8786-8794 https://doi.org/10.1128/MCB.23.23.8786-8794.2003
  27. Kwak, M.K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M. and Kensler, T.W. (2003b). Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem., 278, 8135- 8145 https://doi.org/10.1074/jbc.M211898200
  28. Lam, S., MacAulay, C., Le Riche, J.C., Dyachkova, Y., Coldman, A., Guillaud, M., Hawk, E., Christen, M.O. and Gazdar, A.F. (2002). A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J. Natl. Cancer. Inst., 94, 1001-1009 https://doi.org/10.1093/jnci/94.13.1001
  29. Lee, J.M., Calkins, M.J., Chan, K., Kan, Y.W. and Johnson, J.A. (2003). Identification of the NF-E2-related factor-2- dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem., 278, 12029-12038 https://doi.org/10.1074/jbc.M211558200
  30. Lee, J.M., Chan, K., Kan, Y.W. and Johnson, J.A. (2004). Targeted disruption of Nrf2 causes regenerative immunemediated hemolytic anemia. Proc. Natl. Acad. Sci. USA, 101, 9751-9756
  31. Lee, J.M., Hanson, J.M., Chu, W.A. and Johnson, J.A. (2001). Phosphatidylinositol 3-kinase, not extracellular signal- regulated kinase, regulates activation of the antioxidant- responsive element in IMR-32 human neuroblastoma cells. J. Biol. Chem., 276, 20011-20016 https://doi.org/10.1074/jbc.M100734200
  32. Li, J., Stein, T.D. and Johnson, J.A. (2004). Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice. Physiol. Genomics, 18, 261-272 https://doi.org/10.1152/physiolgenomics.00209.2003
  33. McMahon, M., Itoh, K., Yamamoto, M., Chanas, S.A., Henderson, C.J., McLellan, L.I., Wolf, C.R., Cavin, C. and Hayes, J.D. (2001). The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res., 61, 3299-3307
  34. McMahon, M., Itoh, K., Yamamoto, M. and Hayes, J.D. (2003). Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem., 278, 21592-21600 https://doi.org/10.1074/jbc.M300931200
  35. Nguyen, T., Sherratt, P.J. and Pickett, C.B. (2003). Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol., 43, 233-260 https://doi.org/10.1146/annurev.pharmtox.43.100901.140229
  36. Otieno, M.A., Kensler, T.W. and Guyton, K.Z. (2000). Chemoprotective 3H-1,2-dithiole-3-thione induces antioxidant genes in vivo. Free Radic. Biol. Med., 28, 944-952 https://doi.org/10.1016/S0891-5849(00)00175-1
  37. Primiano, T., Gastel, J.A., Kensler, T.W. and Sutter, T.R. (1996). Isolation of cDNAs representing dithiolethione-responsive genes. Carcinogenesis, 17, 2297-2303 https://doi.org/10.1093/carcin/17.11.2297
  38. Primiano, T., Li, Y., Kensler, T.W., Trush, M.A. and Sutter, T.R. (1998). Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention. Carcinogenesis, 19, 999-1005 https://doi.org/10.1093/carcin/19.6.999
  39. Ramos-Gomez, M., Dolan, P.M., Itoh, K., Yamamoto, M. and Kensler, T.W. (2003). Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice. Carcinogenesis, 24, 461-467 https://doi.org/10.1093/carcin/24.3.461
  40. Ramos-Gomez, M., Kwak, M.K., Dolan, P.M., Itoh, K., Yamamoto, M., Talalay, P. and Kensler, T.W. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor- deficient mice. Proc. Natl. Acad. Sci. USA, 98, 3410- 3415
  41. Rangasamy, T., Cho, C.Y., Thimmulappa, R.K., Zhen, L., Srisuma, S.S., Kensler, T.W., Yamamoto, M., Petrache, I., Tuder, R.M. and Biswal, S. (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest., 114, 1248-1259 https://doi.org/10.1172/JCI200421146
  42. Suh, J.H., Shenvi, S.V., Dixon, B.M., Liu, H., Jaiswal, A.K., Liu, R.M. and Hagen, T.M. (2004). Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. USA, 101, 3381-3386
  43. Talalay, P., De Long, M.J. and Prochaska, H.J. (1988). Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA, 85, 8261-8265
  44. Thimmulappa, R.K., Mai, K.H., Srisuma, S., Kensler, T.W., Yamamoto, M. and Biswal, S. (2002). Identification of Nrf2- regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res., 62, 5196-5203
  45. Venugopal, R. and Jaiswal, A.K. (1996). Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA, 93, 14960-14965
  46. Venugopal, R. and Jaiswal, A.K. (1998). Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene, 17, 3145-3156 https://doi.org/10.1038/sj.onc.1202237
  47. Wakabayashi, N., Dinkova-Kostova, A.T., Holtzclaw, W.D., Kang, M.L., Kobayashi, A., Yamamoto, M., Kensler, T.W. and Talalay, P. (2004). Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. USA, 101, 2040-2045
  48. Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D.R., Harada, T., Engel, J.D. and Yamamoto, M. (2003). Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet., 35, 238- 245 https://doi.org/10.1038/ng1248
  49. Wang, J.S., Shen, X., He, X., Zhu, Y.R., Zhang, B.C., Wang, J.B., Qian, G.S., Kuang, S.Y., Zarba, A., Egner, P.A.,Jacobson, L.P., Munoz, A., Helzlsouer, K.J., Groopman, J.D. and Kensler, T.W. (1999). Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl. Cancer Inst., 91, 347-354 https://doi.org/10.1093/jnci/91.4.347
  50. Wasserman, W.W. and Fahl, W.E. (1997). Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. USA, 94, 5361-5366
  51. Wild, A.C., Moinova, H.R. and Mulcahy, R.T. (1999). Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem., 274, 33627-33636 https://doi.org/10.1074/jbc.274.47.33627
  52. Yoh, K., Itoh, K., Enomoto, A., Hirayama, A., Yamaguchi, N., Kobayashi, M., Morito, N., Koyama, A., Yamamoto, M. and Takahashi, S. (2001). Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int., 60, 1343- 1353 https://doi.org/10.1046/j.1523-1755.2001.00939.x
  53. Zhang, D.D. and Hannink, M. (2003). Distinct cysteine residues in keap1 are required for keap1-dependent ubiquitination of nrf2 and for stabilization of nrf2 by chemopreventive agents and oxidative stress. Mol. Cell Biol., 23, 8137- 8151 https://doi.org/10.1128/MCB.23.22.8137-8151.2003